CoChat

Slow Response to Vancomycin or Vancomycin plus Rifampin in Methicillin-resistant Staphylococcus aureus Endocarditis

Levine, Donald P., Fromm, Barbara S., Reddy, B. Ramesh · 1991 · Annals of Internal Medicine

The DOI matches its Crossref record; 20 of the 21 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To determine the median response time to therapy with vancomycin alone or with vancomycin plus rifampin in patients with methicillin-resistant Staphylococcus aureus (MRSA) endocarditis. DESIGN: Cohort analysis of a randomized study. SETTING: University medical center. PATIENTS: Forty-two consecutive patients with MRSA endocarditis were randomly assigned to receive either vancomycin (group I) or vancomycin plus rifampin (group II) for 28 days. MEASUREMENTS: Clinical signs and symptoms were recorded, and blood cultures were obtained daily to determine the duration of bacteremia. MAIN RESULTS: The median duration of bacteremia was 9 days (7 days for group I and 9 days for group II). The median duration of fever for all patients and for each treatment group was 7 days. Six patients failed therapy, including three patients who died 5, 6, and 9 days after therapy was started, respectively. The other three patients who failed therapy required valve surgery on days 2, 22, and 27, respectively. Although patients had sustained bacteremia, no unusual complications were seen in either treatment group, and most patients responded to continued antibiotic therapy. CONCLUSIONS: Slow clinical response is common among patients with MRSA endocarditis who are treated with vancomycin or vancomycin plus rifampin. Nevertheless, few complications appear to be related solely to this sustained bacteremia.

Overview

Integrity signals

Registry

Crossref · 10.7326/0003-4819-115-9-674

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 20 references

Research works printed but not linked: 1

  1. 10.1001/jama.1976.03270150038029 · doi:10.1001/jama.1976.03270150038029

Cited by

See all 592

Metadata

Authors
Levine, D. P., Fromm, B. S., & Reddy, B. R.
Affiliations
  • Wayne State University (US)
  • Harper University Hospital (US)
Venue
Annals of Internal Medicine
Published
1991-11-01
Volume
115
Issue
9
Pages
674-680
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W1975150477
Cited by
577
References
21
Citations by year
2025: 2 · 2024: 9 · 2023: 10 · 2022: 4 · 2021: 5 · 2020: 7 · 2019: 5 · 2018: 10 · 2017: 9 · 2016: 12 · 2015: 21 · 2014: 12 · 2013: 27 · 2012: 10
FWCI
12.57
Type
journal article
Language
en
Open access
closed
Locations
  • Annals of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
  • Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
Keywords
MRSA endocarditis, methicillin-resistant Staphylococcus aureus, vancomycin, rifampicin, combination antibiotic therapy, treatment response time, fever duration, treatment failure, valve surgery
MeSH terms
Adult, Drug Therapy, Combination, Endocarditis, Bacterial, Female, Fever, Gentamicins, Humans, Male, Middle Aged, Prospective Studies, Rifampin, Staphylococcal Infections, Statistics as Topic, Time Factors, Vancomycin, Methicillin Resistance, Bacteremia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Slow Response to Vancomycin or Vancomycin plus Rifampin in Methicillin-resistant Staphylococcus aureus Endocarditis. https://app.cochat.ai/papers/10.7326/0003-4819-115-9-674
The paper
Levine, D. P., Fromm, B. S., & Reddy, B. R. (1991). Slow Response to Vancomycin or Vancomycin plus Rifampin in Methicillin-resistant Staphylococcus aureus Endocarditis. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-115-9-674

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.